IMMX Stock Analysis: Buy, Sell, or Hold?
IMMX - Immix Biopharma, Inc. Common Stock
$5.83
-0.12 (-2.02%)
▼
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Mar 23, 2026
Smart Money Distribution
IMMX is up 8.4% this week, but smart money is buying puts. Top strike: $5 2026-03-20 with 24 OI. Put ratio: 100% View Scanner →
Strength: 9.2/10
Get Alerted When IMMX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called IMMX this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: IMMX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: IMMX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: IMMX is currently trading at $5.83, which is considered extended relative to its 30-day fair value range of $4.78 to $5.69.
Technical Outlook: Technically, IMMX is in a strong uptrend. Immediate support is located at $4.54, while resistance sits at $6.33.
Market Sentiment: IMMX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $9.60 (+64.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, IMMX is in a strong uptrend. Immediate support is located at $4.54, while resistance sits at $6.33.
Market Sentiment: IMMX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $9.60 (+64.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$4.78 -
$5.69
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 64.7% below Wall St target ($9.60)
Fair Price Analysis
30-Day Fair Range
$4.78 -
$5.69
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$4.54
Resistance Level
$6.33
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-12.40
Wall Street Target
$9.60
(+64.7%)
Last updated: February 01, 2026 6:21 PM ET
Data refreshes hourly during market hours. Next update: 7:21 PM
Data refreshes hourly during market hours. Next update: 7:21 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IMMX showing a specific setup today?
Insider Activity (6 Months)
2
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Ilya M Rachman
BUY
2500 shares
2025-09-17
Gabriel S Morris
BUY
2600 shares
2025-09-16
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$404 | 63 BUY |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$215 | 60 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$64 | 55 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 53 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$102 | 62 BUY |
